Literature DB >> 15682009

Toward an understanding of dural ectasia: a light microscopy study in a murine model of Marfan syndrome.

Kevin B Jones1, Loretha Myers, Daniel P Judge, Patricia A Kirby, Harry C Dietz, Paul D Sponseller.   

Abstract

STUDY
DESIGN: Light microscopy study of the lumbar spinal meninges of a murine model of Marfan syndrome.
OBJECTIVE: Characterize the pathology of the lumbosacral meninges in Marfan syndrome, seeking clues to the pathophysiology behind dural ectasia. SUMMARY OF BACKGROUND DATA: Dural ectasia is common in Marfan syndrome. The etiology of dural ectasia is unknown, but is conjectured to be related to constitutionally weak spinal dura. The morphology of the lumbar dura in Marfan syndrome has not been described, as it has in other tissues affected by Marfan syndrome.
METHODS: The lumbosacral dura were removed from three 4-month-old mice, 1 homozygote (mgR/mgR) expressing the murine Marfan phenotype, 1 heterozygote expressing wild-type phenotype, and 1 homozygote wildtype. Hematoxylin and eosin, elastochrome, and immunohistochemical stains against activated transforming growth factor beta, gelatinase A (matrix metalloproteinase-2), and gelatinase-B (matrix metalloproteinase-9) were used for light microscopic evaluation.
RESULTS: No difference was noted between the heterozygous and wild-type mice in dural connective tissue morphology. The homozygote (mgR/mgR) had a marked attenuation of the dura overall, in addition to elastic fiber disorganization. The homozygote dura also stained for increased presence of activated transforming growth factor beta and matrix metalloproteinase-2, but not matrix metalloproteinase-9.
CONCLUSIONS: These morphologic findings in the Marfan phenotype mouse mimic the findings of disordered elastic-fibers in other Marfan tissues and demonstrate gross attenuation of the tissue architecture, corroborating the theory that dural ectasia in Marfan syndrome results from hydrostatic pressure on weakened dura. These changes may be due in part to transforming growth factor beta overactivation and gelatinase-A-mediated elastolysis and collagen breakdown.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682009     DOI: 10.1097/01.brs.0000152166.88174.1c

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  17 in total

Review 1.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

2.  ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation.

Authors:  Carine Le Goff; Fanny Morice-Picard; Nathalie Dagoneau; Lauren W Wang; Claire Perrot; Yanick J Crow; Florence Bauer; Elisabeth Flori; Catherine Prost-Squarcioni; Deborah Krakow; Gaoxiang Ge; Daniel S Greenspan; Damien Bonnet; Martine Le Merrer; Arnold Munnich; Suneel S Apte; Valérie Cormier-Daire
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

Review 3.  [Spontaneous intracranial hypotension and Marfan syndrome].

Authors:  A Apetroae; T Strenzke; A Ferbert; P D Schellinger
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

Review 4.  Recent progress in genetics of Marfan syndrome and Marfan-associated disorders.

Authors:  Takeshi Mizuguchi; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2006-10-24       Impact factor: 3.172

Review 5.  Mitral valve disease in Marfan syndrome and related disorders.

Authors:  Daniel P Judge; Rosanne Rouf; Jennifer Habashi; Harry C Dietz
Journal:  J Cardiovasc Transl Res       Date:  2011-08-25       Impact factor: 4.132

6.  Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.

Authors:  B L Loeys; E E Gerber; D Riegert-Johnson; S Iqbal; P Whiteman; V McConnell; C R Chillakuri; D Macaya; P J Coucke; A De Paepe; D P Judge; F Wigley; E C Davis; H J Mardon; P Handford; D R Keene; L Y Sakai; H C Dietz
Journal:  Sci Transl Med       Date:  2010-03-17       Impact factor: 17.956

7.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

Review 8.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

9.  Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.

Authors:  H H Clarice Yang; Jong Moo Kim; Elliott Chum; Cornelis van Breemen; Ada W Y Chung
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

10.  Spinal imaging features in Japanese patients with Marfan syndrome: a case-control study.

Authors:  Eri Hayashida; Daisuke Utsunomiya; Akira Sasao; Tsuyoshi Yasuda; Toshinori Hirai; Hideaki Yuki; Seitaro Oda; Joji Urata; Akihiko Arakawa; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2014-01-30       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.